XELJANZ / XELJANZ XR (tofacitinib) 2 Contraindications

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

XELJANZ/XELJANZ XR (tofacitinib) is contraindicated:

  • In patients with known hypersensitivity to tofacitinib or ingredient in the formulation, including any non-medicinal ingredient, or component of the container. For a complete listing, see DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.
  • In patients with severe hepatic impairment (see 7 WARNINGS AND PRECAUTIONS).
  • During pregnancy and breastfeeding (see 1.1 Pregnancy and 7.1.2 Breast-feeding).